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Abstract
Virulence of complex pathogens in mammals is generally determined by multiple components of the pathogen interacting
with the functional complexity and multiple layering of the mammalian immune system. It is most unusual for the
resistance of a mammalian host to be overcome by the defeat of a single defence mechanism. In this study we uncover and
analyse just such a case at the molecular level, involving the widespread intracellular protozoan pathogen Toxoplasma
gondii and one of its most important natural hosts, the house mouse (Mus musculus). Natural polymorphism in virulence of
Eurasian T. gondii strains for mice has been correlated in genetic screens with the expression of polymorphic rhoptry kinases
(ROP kinases) secreted into the host cell during infection. We show that the molecular targets of the virulent allelic form of
ROP18 kinase are members of a family of cellular GTPases, the interferon-inducible IRG (immunity-related GTPase) proteins,
known from earlier work to be essential resistance factors in mice against avirulent strains of T. gondii. Virulent T. gondii
strain ROP18 kinase phosphorylates several mouse IRG proteins. We show that the parasite kinase phosphorylates host Irga6
at two threonines in the nucleotide-binding domain, biochemically inactivating the GTPase and inhibiting its accumulation
and action at the T. gondii parasitophorous vacuole membrane. Our analysis identifies the conformationally active switch I
region of the GTP-binding site as an Achilles’ heel of the IRG protein pathogen-resistance mechanism. The polymorphism of
ROP18 in natural T. gondii populations indicates the existence of a dynamic, rapidly evolving ecological relationship
between parasite virulence factors and host resistance factors. This system should be unusually fruitful for analysis at both
ecological and molecular levels since both T. gondii and the mouse are widespread and abundant in the wild and are well-
established model species with excellent analytical tools available.
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Introduction
Toxoplasma gondii is an intracellular protozoan parasite with a
complex life cycle and is distantly related to the malarial genus
Plasmodium. The sexual phase occurs only in the true cats (Felidae),
while all warm-blooded animals including humans can be
intermediate hosts. The infection is transmitted from cats to
intermediate hosts via ingestion of oocysts from the faeces of
infected cats, and from intermediate hosts back to cats by
carnivory. Typically, T. gondii establishes a lifelong chronic
infection in intermediate hosts by encysting, after an initial phase
of rapid intracellular proliferation and cell–cell spread, in brain
and muscle. The life cycle is completed when the infected host is
eaten by a cat [1]. However, some T. gondii strains are highly
virulent for mice, killing the host as early as ten days after initial
infection. Of the three clonal lineages of T. gondii commonly found
in Eurasia and North America [2,3], the type I strains are highly
virulent for mice [4]. In a genetic cross between a type I virulent
and a type III avirulent strain, the serine-threonine kinase secreted
from rhoptry organelles, ROP18 [5], emerged as a major viru-
lence factor [6]. In another genetic cross, ROP16 kinase and the
ROP5 pseudokinases were implicated in virulence differences
between type II and type III strains [7]. Comparative studies
of ROP18 from multiple T. gondii strains, including the major
Eurasian types, established that this virulence protein shows ex-
tensive polymorphic sequence variation derived from recent
episodes of positive selection [8].
In mice the major resistance factors preventing acute death
from avirulent T. gondii infection, and thereby allowing T. gondii
transmission, are large GTPases of the immunity-related GTPase
(IRG) family [9,10]. These interferon-c (IFNc)-inducible proteins
accumulate on the parasitophorous vacuole membrane (PVM)
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within minutes after infection of a cell by an avirulent T. gondii
strain [11,12]. The PVM becomes vesiculated then disrupted, and
the parasite is killed [11,13,14]. Encoded by about 15 active genes
in the C57BL/6 mouse genome ([15] and unpublished results), the
IRG proteins function interactively and nonredundantly in
resistance [16], so that disruption of single members of the family
cause highly significant early mortality following infection with
avirulent strains [9]. However, during infection by a type I virulent
T. gondii strain, few vacuoles accumulate IRG proteins in large
amounts or disrupt [12,14,17,18], and parasite replication in cells
is not inhibited by IFNc [17]. These parallel observations on
parasite virulence and host resistance suggested that IRG proteins
might be phosphorylated and inactivated by ROP kinases from
virulent strain T. gondii.
The switch I and switch II loops of the GTP-binding domain of
GTPases are sequence elements whose conformational changes
during the GTP-binding and hydrolysis cycle largely determine
the functional activity of the protein via its interaction with other
proteins [19,20]. In classical Ras-like small GTPases the switch
I loop contains a conserved threonine (the ‘‘G2 threonine’’)
interacting with a catalytically important Mg2+ ion. In Irga6, the
only IRG protein for which structural [21], biochemical ([22] and
Pawlowski et al., unpublished data), and functional ([11] and
Liesenfeld et al., unpublished data) information is available, highly
conserved threonines are present in the switch I loop, but the
typical Ras configuration is not seen and these residues do not
coordinate the Mg2+ ion [21]. We show here that the ROP18
kinase from highly virulent strains targets Irga6, phosphorylating
two threonines in the switch I loop. For Irga6, the switch I loop
from residues 100 to 109 is implicated in the formation of a critical
dimer interface with a neighbouring Irga6 molecule during the
process of GTP-dependent activation and subsequent hydrolysis
(Pawlowski et al., unpublished data). We present evidence that
phosphorylation of either of the target threonines inactivates the
GTPase and inhibits its normal accumulation on the PVM.
Virulent strains also phosphorylate other IRG resistance proteins,
and other ROP kinase homologues have been associated with
virulence, suggesting that this will prove to be a general
mechanism by which T. gondii moderates the IRG system, thus
favouring long-term survival of both parasite and host.
Results
We looked directly for phosphorylation of the mouse IRG
protein Irga6, which we immunoprecipitated from T. gondii-
infected fibroblasts. IFNc-induced fibroblasts were labelled in
parallel with 33P-phosphoric acid or 35S-methionine/cysteine and
infected with the virulent type I RH-YFP strain T. gondii (Figure 1).
A single phosphorylated protein was immunoprecipitated corre-
sponding to the upper band of a doublet metabolically labelled
with 35S-methionine/cysteine, and found only in infected cells
(Figure 1A). The single phosphorylated band was found only in
immunoprecipitates from virulent strain infections (Figure 1B, type
I strains RH-YFP and BK). The 33P-labelled band is not due to
another protein coprecipitated with Irga6 since it could also be
detected by Western blot with monoclonal and polyclonal
antibody reagents specific for Irga6 (Figure 1C and unpublished
data). Irga6 is a myristoylated protein [23], and nonmyristoylated
Irga6 also runs slightly slower than native myristoylated protein
([24] and unpublished data). However, both Irga6 bands in
immunoprecipitates from the virulent strain infections incorporat-
ed 3H-myristic acid (Figure 1D), and are therefore myristoylated.
Thus, infection by virulent strains of T. gondii, but not by avirulent
strains, results in significant phosphorylation of native, myristoy-
lated Irga6.
The phosphorylated sites on Irga6 were identified by mass
spectrometry (MS) analysis of the phosphorylated Irga6 band
immunoprecipitated from IFNc-induced fibroblasts infected with
RH-YFP. Tryptic peptides were found corresponding in mass
to phosphorylated derivatives of a region of the switch I loop of
the nucleotide binding domain containing two closely-spaced
threonines, T102 and T108 (Figure 2). Putatively phosphorylated
peptides containing both target threonines, corresponded in
molecular mass exclusively to monophosphorylated derivatives
(Figure 2A). To confirm the phosphorylation of the two minimal
peptides, the candidates were further resolved by CID (collision-
induced dissociation) MS/MS (Figure S1).
Among the crystal structures available for Irga6 [21], T102 and
T108 are found in several different configurations (Figure 2B). In
one structure (Protein Data Bank [PDB] 1TQ6), the side chain of
T102 is close to the nucleotide, while the side chain of T108 is
distant from the nucleotide and largely exposed to solvent
(Figure 2B, left graphic). In another (PDB 1TQ2B), T108 is
oriented towards the nucleotide, while T102 is rotated away from
the nucleotide (Figure 2B, right graphic). The alternation between
the two structures correlates with the presence or absence of a
short helical turn in the switch I loop. Phosphorylation of one
threonine may lock one configuration for the switch I loop,
preventing kinase access to the second threonine. Unlike the
classical G2 threonine of many small GTPases, neither T102 nor
T108 interacts with the Mg2+ ion in any Irga6 structure so far
studied [21]. T108 is absolutely conserved among all the IRG
proteins, while T102 is highly but not completely conserved
(Figure 2C).
That T102 and T108 are targets of phosphorylation by virulent
T. gondii strains in infected cells was confirmed by Western blot of
T. gondii-infected, IFNc-induced cells with two rabbit antisera
raised respectively against peptides of Irga6 containing phospho-
T102 and phospho-T108. After affinity purification both antibod-
ies identified a single band in IFNc-induced wild-type (wt)
Author Summary
Many pathogens manipulate the immune system of their
hosts to facilitate infection and ensure transmission to
subsequent hosts. The intracellular protozoan Toxoplasma
gondii, a relative of the malaria parasite, is able to infect and
persist in a remarkable variety of warm-blooded hosts.
Indeed roughly a third of the human race carry live
Toxoplasma cysts in their brains with no overt effects.
Toxoplasma infection is kept at bay in many mammals (but
not in humans) by a resistance system based on a family of
proteins known as the immunity-related GTPase (IRG) family.
IRG proteins accumulate in infected cells on the vacuoles
containing the parasite and ultimately destroy them. In this
paper, we show that, in the mouse, Toxoplasma can oppose
the IRG system by secreting an enzyme called ROP18 into
infected cells, which phosphorylates key amino acids on the
IRG proteins, rendering them inactive. Not all strains of
Toxoplasma can produce an active form of ROP18, but those
strains that do are more virulent. We propose that individual
hosts control Toxoplasma with differing efficiency, and the
variation we see in ROP18 kinase activity produced by
different Toxoplasma strains is an evolutionary response
to this. Thus, in different mammalian hosts, each strain seeks
a balance between an excess of virulence (resulting in
premature death of the host) and resistance that is too
efficient (resulting in clearance of the parasite and sterile
immunity).
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fibroblasts infected with virulent RH-YFP strain T. gondii. This
band was not found in uninduced, infected fibroblasts nor in
induced, uninfected fibroblasts. Most significantly, it was also not
found in IFNc-induced fibroblasts infected with the avirulent
strains ME49 (type II) and CTG (type III) (Figure 3A). The same
cell lysates were probed with an anti-Irga6 antibody to confirm the
expression of Irga6 in the IFNc-induced samples (Figure 3B). The
specificity of the two anti-phosphopeptide reagents for phosphor-
ylated Irga6 was further confirmed by Western blot on IFNc-
induced Irga6-deficient fibroblasts infected with RH-YFP strain
parasites, where no signals were detected (Figure S2A).
To examine the probable impact of phosphorylation at the two
target threonines we assayed the functional properties of two sets
of bacterially expressed mutant Irga6 proteins: (1) negatively
charged, phosphomimetic aspartic acid mutants T102D, T108D
and the double mutant T102/108D and (2) neutral alanine
mutants T102A, T108A and T102/108A, compared with the wt
Irga6 protein [22]. All the T102 and T108 mutations, whether
phosphomimetic or neutral, essentially abolished GTP hydrolysis
(Figure 4A and 4B) and strongly inhibited GTP-dependent
oligomerisation (Figure 4C and 4D). The affinities of all the Thr
to Ala mutants were in the wt range for both GTP and GDP, while
the affinities of the T102D and T102/108D mutants for GDP
were about an order of magnitude lower than wt (Table S1).
For further functional analysis, we expressed the six mutant
proteins and wt Irga6, tagged at the C terminus, by transfection in
IFNc-induced mouse embryonic fibroblasts (MEFs) infected with
the avirulent ME49 strain T. gondii. The proportion of vacuoles
detectably loaded with the mutant Irga6 proteins was in all cases
lower than the values for the tagged wt Irga6 (shown for the
phosphomimetic Thr to Asp mutants, Figure 5A), though in no
case eliminated. The amount of the mutant Irga6 proteins
accumulated onto individual loaded vacuoles was, however,
greatly reduced (Figure 5B). In addition, the mutant proteins
had a weak but consistent dominant negative action on the
accumulation of wt Irga6 on the PVM, perhaps by interference
with homomeric or heteromeric oligomerisation of active Irga6
protein at the PVM (Figure 5C). This could contribute to the
biological effect of the kinase even if not all target IRG molecules
are phosphorylated. In conclusion, Irga6 mutated at T102 or
T108 is inactive biochemically, is impaired in access to the PVM
compared with wt protein, and inhibits to some degree the loading
of wt Irga6 onto the PVM. The fact that the Thr to Ala mutants
were essentially as impaired as the phosphomimetic Thr to Asp
mutants (Figures 4 and 5; unpublished data) indicates that
phosphorylation acts by interfering with the function of two
essential threonines in the switch I region of Irga6, rather than
through some active property conferred by the additional negative
charge or of the phosphate group itself.
The anti-pT102 and anti-pT108 antibodies detected phosphor-
ylated Irga6 by immunofluorescence on the PVM of virulent RH
strain T. gondii in IFNc-induced cells. Irga6 normally accumulates
on the majority of virulent strain vacuoles, but the amount of Irga6
accumulated is much lower than on the vacuoles of avirulent
strains [12]. Both anti-phosphopeptide antibodies stained the
majority of RH vacuoles (Figure 6A and 6B). Significant but much
weaker staining of Irga6(pT108), but not Irga6(pT102), was also
present on some vacuoles of the avirulent ME49 strain: the ME49
vacuole stained with anti-pT108 in Figure 6B (bottom right image)
is a barely visible example. The basis for the weak but significant
Figure 1. Irga6 is phosphorylated by type I virulent T. gondii. (A) A novel phosphorylated Irga6 band (black arrowhead) was
immunoprecipitated with the monoclonal anti-Irga6 antibody, 10E7, from RH-YFP-infected, IFNc-induced mouse L929 cells metabolically labelled
with 35S-methionine/cysteine or 33P-phosphoric acid. Nonphosphorylated Irga6 is indicated with an open arrowhead. The figure is a montage from
two segments of a single autoradiogram, joined as indicated by black vertical line. (B) Only virulent T. gondii strains phosphorylate Irga6. MEFs were
induced with IFNc, infected with virulent type I and avirulent type II and type III strains, and labelled with 33P-phosphoric acid. A single
phosphorylated band (black arrowhead) was immunoprecipitated with 10E7 only from cells infected with type I strains. The figure is a montage of
segments from several autoradiograms, joined as indicated by the black vertical lines. Phosphorylated Irga6 from cells infected with RH-YFP served as
positive control for all segments (not shown). (C) The electrophoretically more slowly migrating phosphorylated band (black arrowhead),
immunoprecipitated with anti-Irga6 165 antiserum from IFNc-induced L929 cells infected with virulent strain RH-YFP, is Irga6 and not a
coprecipitated protein (Western blot with 10E7). Only the faster band of Irga6 is immunoprecipitated from cells infected with avirulent ME49 strain
(open arrowhead). (D) Both Irga6 bands were immunoprecipitated with 10E7 from RH-YFP-infected IFNc-induced L929 cells labelled with 3H-myristic
acid (autoradiogram). In the absence of infection only the lower myristoylated band is seen. Black arrowhead: myristoylated phosphorylated Irga6
(myr-(p)Irga6). Open arrowhead: myristoylated Irga6 (myr-Irga6).
doi:10.1371/journal.pbio.1000576.g001
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signals of the anti-pT108 antibodies on ME49 vacuoles is not yet
clear. No staining of either anti-pT102 or anti-pT108 antibodies
was seen on virulent strain vacuoles in IFNc-induced cells from
Irga6-deficient mice (Figure S2B) or on virulent or avirulent strain
vacuoles in uninduced cells (Figure S3).
ROP18 is an active T. gondii kinase that occurs in different allelic
forms in the three Eurasian and North American clonal lineages
[8]. The protein is secreted directly from apical secretory
organelles (rhoptries) into the cytosol locally at the site of cell
invasion, and it accumulates on the cytosolic face of the PVM of
the invading organism [5,25]. It is thus well-placed to interfere
with the accumulation of IRG proteins on the PVM. If ROP18 is
responsible for the phosphorylation of Irga6 in vivo, this property
should be conferred on a type III avirulent strain (CTG) transgenic
for expression of active ROP18 from the virulent type I strain,
GT-1, which is identical to RH strain ROP18 in sequence ([5] and
TGGT1_063760 on ToxoDB, http://toxodb.org). Indeed this
strain has been shown to gain virulence both in vivo [6] and in
vitro [26]. We therefore infected IFNc-induced primary MEFs
with the CTG-ROP18 transgenic (CTG V1), and, as controls,
with CTG transgenic for a kinase-dead mutant of ROP18
(ROP18-D394A; CTG L1) and CTG transgenic for the empty
vector (CTG Ble) [6]. We detected phosphorylation of Irga6 by
metabolic labelling with inorganic 33P-phosphate and autoradiog-
raphy only from cells infected with the CTG strain transgenic for
the active kinase (CTG V1, Figure 7A), and the phosphothreo-
nine-specific antibodies also detected a signal in Western blot only
in lysates from the CTG V1 strain–infected cells (Figure 7B).
Strong immunofluorescent staining by anti-pT102 and anti-pT108
antibodies was seen on vacuoles from the active ROP18 transgenic
(Figure 8). The great majority of CTG V1 vacuoles were stained
(Figure 8A, red), while few vacuoles of the kinase-dead ROP18
(CTG L1, green) and vector only (CTG Ble, black) transgenic T.
gondii strains were stained. Furthermore, the intensity of staining of
the phosphothreonine antibodies was also strikingly higher on
the CTG V1 vacuoles (Figure 8B and 8C). No staining of the
anti-phosphothreonine antibodies was detected on any of the
transgenic CTG strain vacuoles in cells not induced with IFNc
(Figure S4). However, significant but weak staining with anti-
pT108 antibody was seen on the vacuoles of the CTG strains
transgenic for the empty vector and for the kinase-dead ROP18 in
IFNc-induced cells (Figure 8B), echoing the weak staining of
Figure 2. Irga6 is phosphorylated at T102 and T108 in the switch I loop. (A) MALDI-TOF spectra of tryptic digests of immunoprecipitated
phosphorylated (upper profile) and nonphosphorylated (lower profile) Irga6 from IFNc-induced, RH-infected MEFs. The partial spectra on the left are
focused on the m/z 2176.1, corresponding to the nonphosphorylated tryptic Irga6 peptide G91IGNEEEGAAKTGVVEVTMER111. The partial spectra to
the right are focused on m/z 2256.0, corresponding to the same peptide monophosphorylated on either T102 or T108. The isotopic pattern of m/z
2256.0 in the phosphorylated material is partially overlaid by a pattern of unknown identity at m/z 2259.1. (B) The switch I region (green) occurs in
different configurations in Irga6 crystals [21] (ribbon presentation). T102 and T108 are labelled in red. In PDB structure 1TQ6, T108 is turned outwards
while T102 points towards the nucleotide. In PDB 1TQ2B, T108 is turned inwards, pointing towards the c-phosphate, while T102 is rotated away from
the nucleotide (GppNHp in stick format; grey sphere: Mg2+ ion). (C) ClustalW alignment of the amino acid sequence between the first (G1) and the
third (G3) nucleotide binding motifs (red boxes) of the mouse IRG proteins [15]. Irga5 and Irgb7 are both severely disabled pseudogenes and are not
included in the alignment. There is to date no evidence for a protein product from Irga1, Irga2, and Irga8 (indicated by *), while eight of the IRGB units
are expressed in the form of four head-to-tail tandem proteins (b2-b1, b5-b4, b5*-b3, and b9-b8), indicated by brackets ([15] and unpublished data).
Note that there are two identical copies of Irgb5 (Irgb5 and Irgb5*) present in the C57BL/6 genome [15] represented by one sequence in the
alignment. The switch I region is indicated below the alignment. The T108 residue of Irga6 is absolutely conserved in the other IRG proteins, while the
T102 of Irga6 is largely conserved (green boxes). Amino acid positions indicated above the alignment refer to Irga6, the ones indicated on the left on
the alignment refer to the respective IRG. Shading indicates degree of conservation (black: 90%, grey: 60%).
doi:10.1371/journal.pbio.1000576.g002
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ME49 vacuoles by anti-pT108 antibody already noted in Figure 6.
That phosphorylation of Irga6 by virulent ROP18 interferes with
Irga6 function, already hinted at by the weak dominant negative
effect of the Thr to Asp phosphomimetic mutant proteins shown in
Figure 5C, is reflected in a drop in the overall intensity of Irga6 on
the vacuoles of cells infected with the CTG V1 strain relative to
the staining seen with the two control strains especially at low
IFNc concentrations (Figure 8D). We consider it likely that
phosphorylation of Irga6 by virulent ROP18 occurs at the vacuole,
and that the reduced loading observed is due to destabilization of
interactions between IRG molecules and possibly also to
conformational changes affecting the positioning of the myristoyl
group required for vacuolar association of Irga6 ([24] and
unpublished data).
The data presented above showed that the presence of virulent
strain ROP18 is required for in vivo phosphorylation of T102 and
T108 of Irga6, but did not show a direct interaction between
ROP18 and Irga6. A direct interaction could, however, be shown
in a yeast two-hybrid assay between both wt and kinase-dead
ROP18 (Figure S5). To demonstrate that type I ROP18 is in fact
an Irga6 kinase with the appropriate specificity, we coincubated
bacterially derived purified full-length mature GST-ROP18-Ty
fusion protein with bacterially derived purified wt Irga6 protein
and the T102A, T108A, and T102/108A mutant proteins in
an in vitro kinase assay, followed by autoradiography on the
products (Figure 9A). The wt and all three mutant proteins were
phosphorylated by ROP18. However, quantitation of the signal
showed a small but consistent reduction for the T102A mutant
and highly significant reductions for both the T108A and the
double mutant (Figure 9B). Little ROP18 autophosphorylation
was detected at the low ROP18 input concentrations used
(indicated in Figure 9A). Confirmation that both T102 and
T108 are direct targets for phosphorylation by type I ROP18 was
provided by strong signals in a Western blot for the anti-pT102
and anti-pT108 antibodies on Irga6 from a parallel in vitro kinase
assay performed with a nonradioactive source of phosphate
(Figure 9C). No signals were detected in this assay by each
reagent on its specific mutant protein, and from neither reagent on
the double mutant protein T102/108A, confirming the specificity
of the assay system. We conclude that type I ROP18 is indeed a
specific and direct kinase of Irga6 T102 and T108. In vitro,
ROP18 clearly also has another minor target of phosphorylation
on Irga6 that we have not identified.
The IRG system specifies a number of proteins that act
cooperatively in organising the destruction of the T. gondii vacuole.
It is therefore of interest that a parallel study has identified a
second IRG protein, Irgb6, as a target for virulent ROP18 kinase,
with strong indications that threonines of the switch I loop are
the targets [27]. In our own studies we can confirm that Irgb6 is
also phosphorylated in IFNc-induced cells infected by the virulent
Figure 3. Rabbit anti-pT102 and anti-pT108 peptide antibodies
are specific for phosphorylated Irga6. (A) Western blot of
detergent lysates of IFNc-induced L929 cells either uninfected or
infected with type I RH-YFP, type II ME49, or type III CTG T. gondii. Only
RH-YFP infection caused phosphorylation of Irga6, detectable as a
unique band (black arrowhead) with the anti-pT102 (upper blot) or anti-
pT108 antibodies (lower blot). (B) Western blot of the same lysates as in
Figure 3A in which Irga6 was detected with the monoclonal anti-Irga6
antibody 10E7. The phosphorylated slower-migrating band is detect-
able only in the lysate from cells infected with virulent RH-YFP. Black
arrowhead: phosphorylated Irga6 ((p)Irga6). Open arrowhead: Irga6.
Note that the detectability of the phosphorylated bands by the anti-
pT102 and anti-pT108 antibodies in (A) is independent of variations in
the level of total Irga6.
doi:10.1371/journal.pbio.1000576.g003
Figure 4. Phosphomimetic and neutral mutations of T102 and
T108 disable Irga6 biochemically. (A and B) GTP hydrolysis by
recombinant Irga6 is lost by phosphomimetic Thr to Asp (A) and neutral
Thr to Ala (B) mutations. (C and D) GTP-dependent oligomerisation of
recombinant Irga6 is lost by Thr to Asp (C) and Thr to Ala (D) mutations.
Very weak oligomerisation is retained by T108D.
doi:10.1371/journal.pbio.1000576.g004
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RH-YFP strain, although the level of phosphorylation is
considerably lower than that of Irga6 (Figure S6A). Likewise,
Irgb10 is phosphorylated by RH-YFP, but in IFNc-induced cells
though very weakly above a significant level of intrinsic, infection-
independent phosphorylation (Figure S6B). Strong phosphoryla-
tion of Irgb10 dependent on RH-YFP infection was, however, seen
in cells transfected with a plasmid expressing Irgb10 (Figure S6C).
Some infection-independent phosphorylation of Irgb10 was also
apparent in this experiment. Further analysis is required to
establish whether the phosphorylation of Irgb10 involves the same
target residues as phosphorylation of Irga6 by virulent ROP18.
Discussion
Taken together, our results strongly support the hypothesis that
the virulence of type I T. gondii strains for mice is due at least in
part to their ability to inactivate host IRG resistance proteins by
targeted phosphorylation of threonine residues in the switch I loop
by ROP18 kinase. Threonine residues form part of the catalytic
interface essential for the formation of the GTP-dependent active
dimer, and their modification, like that of all the residues in the
catalytic interface (Pawlowski et al., unpublished data), would be
expected to inactivate the resistance protein. The threonine
corresponding to T108 is conserved throughout the entire family
of IRG proteins in the mouse, and in Irga6 appears to be
quantitatively the major target of phosphorylation by type I
ROP18 (Figure 9). We and Fentress et al. [27] have shown both
Irgb6 and Irgb10 can be phosphorylated and Fentress et al. have
shown that Irgb6 can be phosphorylated by ROP18 in the switch I
loop, predominantly at the threonine homologous to Irga6 T102.
Polymorphism in ROP18 kinase is evidently not the only factor
responsible for reduced IRG protein loading onto the PVM of
virulent strains since the effect is robust to IFNc concentrations
over 100 U/ml with native virulent strains (Figure 6 and [12,17])
but detectable only at IFNc concentrations below 3 U/ml with the
avirulent CTG strain transgenic for ROP18 from a virulent strain
(Figure 8D).
In earlier studies, we [12,17] and another group [18] showed
that the loading of IRG proteins onto the virulent T. gondii vacuole
was seriously impaired, in vitro in IFNc-induced fibroblasts, and in
vivo in primed peritoneal macrophages. Irga6 loading intensity
was substantially reduced, though the number of Irga6-positive
vacuoles was not much affected, while the loading of Irgb6 and
Irgb10 was completely eliminated on the great majority of
vacuoles. At that time, both groups tried to show that virulent-
strain ROP18 kinase was responsible for these effects, we by
transfection of mature virulent ROP18 from RH strain into cells
infected with the avirulent type II strain, ME49 [12], the other
group by infection in vitro with the same avirulent type III CTG
strain transgenic for virulent GT-1 strain ROP18, and the two
control strains used in the present report [18]. Neither group saw
any diminution in IRG protein loading and consequently
concluded that ROP18 was not responsible for the differential
loading of IRG proteins. How are these earlier findings to be
reconciled with the present data, and with the data of Fentress
et al. [27]? Our present view is that the earlier failures to show an
effect of virulent ROP18 were due to the very high level of
cytokine-induced activation of the target cells, in our case with
200 U IFNc/ml, in the case of the other group following an
intense in vivo priming regimen [18]. The present experiments
show a highly significant effect of the CTG virulent ROP18
transgenic strain (CTG V1) on Irga6 loading only at an IFNc dose
of 0.3 U/ml (Figure 8D). Thus virulent ROP18 alone is
apparently unable to recapitulate the striking failures of IRG
protein loading onto the vacuoles seen even at very high levels of
cytokine activation during infection with native virulent type I T.
gondii strains. Nevertheless, the transgenic virulent ROP18 has
been shown to have a substantial influence on virulence in a mouse
mortality assay [6] and on growth and survival of the parasites in
IFNc-induced macrophages [27]. A plausible conclusion is that
there are other factors in T. gondii, over and above ROP18, that
can interfere with IRG protein loading onto the vacuoles of type I
virulent strains. Future experiments should be directed towards the
identification of these factors.
Figure 5. Phosphomimetic Irga6 mutants load onto the PVM inefficiently and inhibit loading of wt Irga6. Wt and phosphomimetic
Irga6 mutants T102D and T108D, all tagged with ctag1, were transfected into IFNc-induced C57BL/6 MEFs. Cells were infected 24 h later with T.
gondii strain ME49 for 2 h and vacuoles assayed for loading of the transfected proteins (A and B) or total Irga6 (C). (A) Frequency of vacuoles loaded
with transfected wt or phosphomimetic mutant Irga6 proteins (mean and standard deviation of four independent experiments, 100 vacuoles
counted per experiment). (B) Loading intensity of transfected wt or phosphomimetic mutant Irga6 proteins (40 vacuoles analysed; *** p,0.0001;
horizontal lines indicate means). (C) Frequency of vacuoles loaded with total Irga6 detected with the monoclonal anti-Irga6 antibody 10D7. The
transfected phosphomimetic mutant proteins reduced the frequency of vacuoles loaded with endogenous Irga6 (results of two independent
experiments, 100 vacuoles counted per experiment).
doi:10.1371/journal.pbio.1000576.g005
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For some time now, it has been clear that the striking virulence
differential for mice between the three clonal lineages of T. gondii
abundant in Eurasia and North America is not reflected in
anything comparable in terms of their virulence for humans.
There are important clinical differences but it has not been
possible to designate these clearly as differences in virulence [26].
Our findings offer an interesting form of explanation for this well-
established observation since the molecular targets of ROP18 in
mouse cells, IFN-inducible IRG proteins, are not present in
humans, having been lost in the primate lineage before the
separation of the Old and New World monkeys [15,28]. Humans
organise their resistance to T. gondii along other lines, perhaps
involving IFNc-induced depletion of the essential amino acid
tryptophan [29,30], for which T. gondii is auxotrophic, as well as
other mechanisms [31,32]. The p65 guanylate binding proteins
(GBPs) are also plausible candidates for a human resistance
mechanism against T. gondii [33]. However, these proteins are not
homologous to the IRG proteins and a role in T. gondii resistance
remains to be shown. It is possible therefore that the ROP18
kinase has coevolved with the IRG resistance system, so that in
humans, in the absence of the IRG system, the ROP18 kinase is
nonfunctional and its polymorphism irrelevant. It should be noted
that, although the p65 GBPs have a G2 threonine residue in the
switch I loop [34], there is no significant homology with IRG
proteins elsewhere in the switch I loop [35] or indeed elsewhere in
the entire protein that would suggest they would be targeted by a
common kinase.
The ROP18 alleles of the three clonal lineages differ strikingly
from each other, and there is internal evidence that the protein has
been under recent positive selection [8]. The type II allelic product
differs from the type I product by 22 amino acids out of 541. Type
II ROP18 RNA is expressed at essentially the same level as the
type I ROP18 RNA [8] but our experiments show that type II
strain ROP18 protein is apparently relatively incompetent to
phosphorylate either Irga6 or Irgb6 in IFNc-induced cells. The
type II ROP18 is, however, an active kinase (T. Steinfeldt,
unpublished results), and weak but detectable phosphorylation of
Irga6 was detected in IFNc-induced cells infected with avirulent
type II and III strains. It is not yet clear whether this low level of
phosphorylation is due to type II or type III ROP18 kinase,
respectively. The type III allelic product differs from the type I
product at 78 positions, but perhaps more important, its
expression level is very greatly reduced by a promoter modification
and as a consequence it is considered a null allele [6,8] though it is
not known whether the encoded protein has kinase activity. If the
ROP18 system has been under recent positive selection, it is likely
that small rodents have played an important role as intermediate
hosts because of the recent overwhelming dominance of the
Figure 6. Phosphorylated Irga6 is detected at the PVM in cells infected with virulent T. gondii. IFNc-induced MEFs were infected with the
indicated T. gondii strains for 2 h and immunostained with the anti-pT102 and anti-pT108 antibodies. (A) Staining intensities at virulent RH and
avirulent ME49 strain vacuoles by anti-pT102 and anti-pT108 antibodies. (*** p,0.0001; horizontal lines indicate means). Weak but significant staining
of ME49 vacuoles was recorded from the pT108-specific antibody. One representative out of three independent experiments is shown. (B)
Representative immunofluorescence images of total active Irga6 (first column, 10D7) and phosphorylated Irga6 (second column, anti-pT102 and anti-
pT108 antibodies) on RH (upper two rows) and ME49 (lower two rows) strain parasitophorous vacuoles. Intracellular T. gondii are indicated by arrows
and individual exposure times are indicated in brackets. Corresponding phase contrast images are also given (third column).
doi:10.1371/journal.pbio.1000576.g006
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domestic cat in determining the rate of T. gondii evolution. The
IRG system is well developed in this taxonomic group, plausibly in
response to selection pressure from T. gondii. Thus a functional
explanation for the polymorphism in the ROP18 virulence system
may be found in a better understanding of the specificity and
mode of action of IRG proteins. Recent (unpublished) studies from
our laboratory have shown that the IRG system of mice is itself
highly polymorphic both structurally and functionally, as is
susceptibility to virulent strain T. gondii infection. The fact that
ROP18 is polymorphic may indicate that different alleles are
optimised for different targets, perhaps for other mouse IRG
protein sequences or IRG proteins from other evolutionarily
significant intermediate host species. These considerations also
suggest an explanation for the existence of highly virulent T. gondii
strains in the wild, where they may have a selective advantage in
confrontations with mice carrying highly resistant IRG alleles
capable of providing sterile immunity against less virulent strains.
T. gondii has extensively diversified the ROP kinase family since
its separation from its distant apicomplexan cousin, Plasmodium, in
which these proteins are not found. Other members of the family,
some of which have been described as pseudokinases because of
destructive modification of the catalytic site, have also been
implicated in virulence by genetic studies [7]. Polymorphic
ROP16 kinase has recently been shown to act as a tyrosine kinase
affecting the host cell inflammatory pathways regulated by STAT3
[36] and STAT6 [37], probably by direct phosphorylation and
activation of these latent transcription factors. Future studies will
reveal whether ROP18 is the only member of the ROP kinase
family dedicated to the control of the genetically complex and
rapidly evolving IRG resistance system, not only in the mouse but
also in most mammalian groups outside the higher primates
[15,28]. The IRG resistance system may be modulated to a greater
or lesser extent by ROP kinases and pseudokinases of all T. gondii
strains, each seeking in different mammalian hosts a balance
between an excess of virulence, resulting in premature death of the
host, and too efficient resistance, resulting in clearance of the
parasite and sterile immunity.
The inactivation of IRG proteins by phosphorylation of
essential switch I threonines appears to be a potential Achilles
heel for resistance mediated by IFNc-inducible GTPases. The
switch I and II loops of Rho family GTPases have been extensively
targeted by bacterial glucosylating, deamidating, and ADP-
ribosylating enzymes to favour or inhibit phagocytic uptake [38].
However, the destructive phosphorylation of switch I threonines of
IRG proteins mediated by T. gondii ROP18 kinase appears to be a
novel virulence mechanism, in this case targeted against a
dedicated resistance system rather than a housekeeping protein,
and in this sense resembling in principle the ‘‘gene-for-gene’’
virulence-resistance systems [39] characteristic of R-gene–mediat-
ed immunity in plants [40].
Materials and Methods
T. gondii Strains, In Vitro Passage and Infection of Murine
Fibroblasts
Tachyzoites from T. gondii type I virulent strains RH-YFP [41]
and RH [42], BK [43], type II avirulent strains ME49 [44], NTE
[45] and PRU-YFP [41], and type III avirulent strain CTG [46]
were maintained by serial passage in confluent monolayers
of HS27 cells [11]. Tachyzoites from T. gondii transgenic strains
CTG Ble (a type III strain containing a BleR selectable marker as a
control), CTG L1 (CTG expressing a kinase-dead mutant form
(ROP18-D394A) of the type I GT-1 allele of ROP18 [5], and
CTG V1 (CTG expressing an active form of the type I GT-1 allele
of ROP18) [6] were passaged in HS27 cells as described for the
other T. gondii strains. All tachyzoites were used immediately after
harvest for inoculation of untreated, IFNc-stimulated, and/or
transiently transfected fibroblasts at a multiplicity of infection of 5
to 10 [11].
Cell Culture
Wt and Irga6-deficient [11] MEFs prepared from 14-d wt
C57BL/6 embryos were maintained in DMEM, high glucose
(Invitrogen), supplemented as described above but with 10% FCS
(Biochrom). L929 mouse fibroblasts were cultured in IMDM
(Invitrogen) containing 16 MEM nonessential amino acids,
100 U/ml penicillin, 100 mg/ml streptomycin supplemented with
10% FCS as previously described [14]. Cells were induced for
24 h with 200 U/ml IFNc (Cell Concepts) unless indicated
otherwise.
Cell Extracts and Western Blot Analysis
1–26105 MEFs or 2–46105 L929 cells were seeded to individual
wells of a six-well plate, induced with IFNc or transiently
transfected. Cells were harvested by scraping and centrifugation
and were lysed in 100 ml per well of 0.5% NP-40, 150 mM NaCl,
20 mM Tris/HCl (pH 7.6), 2 mM MgCl2 supplemented with
protease and phosphatase inhibitors (Complete, Mini, EDTA free
Figure 7. Avirulent CTG strain transgenic for virulent ROP18
phosphorylates Irga6 at T102 and T108. (A) Irga6 immunoprecip-
itated from 33P-phosphoric acid–labelled, IFNc-induced L929 cells
infected with CTG strain transgenic for empty vector (CTG Ble),
kinase-dead ROP18-D394A (CTG L1) or active ROP18 from GT-1 strain
(CTG V1) (autoradiogram). Only CTG V1 can phosphorylate Irga6 (black
arrowhead). Virulent RH-YFP is a positive control. (B) Detergent lysates
from IFNc-induced L929 cells infected with CTG Ble, CTG L1, CTG V1, or
RH-YFP were stained in a Western blot with rabbit anti-pT108 or anti-
T102 antibodies. Only CTG V1 and positive control RH-YFP infected cells
show the typical band of phosphorylated Irga6 (black arrowhead).
doi:10.1371/journal.pbio.1000576.g007
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Figure 8. Avirulent CTG strain transgenic for virulent ROP18 phosphorylates Irga6 at the PVM. (A) Frequency of vacuoles positive
for phosphorylated Irga6 detected by immunofluorescence with anti-pT102 and anti-pT108 antibodies in IFNc-induced MEFs infected with CTG Ble
(black), CTG L1 (green), or CTG V1 (red) transgenic T. gondii strains (results of two independent experiments, 100 vacuoles counted per experiment).
(B) Intensity of phosphorylated Ira6 detected by immunofluorescence with anti-pT102 and anti-pT108 antibodies in IFNc-induced MEFs infected
with CTG Ble (black), CTG L1 (green), or CTG V1 (red) transgenic T. gondii strains (20 vacuoles counted; horizontal lines indicate mean signal
intensities; *** p,0.0001). (C) Immunofluorescent images of total active Irga6 (first column, detected with monoclonal anti-Irga6 antibody 10D7) and
phosphorylated Irga6 (second column, detected with anti-pT102 and anti-pT108 antibodies) on CTG V1, Ble, and L1 vacuoles in IFNc-induced MEFs.
Intracellular T. gondii are indicated by arrows and individual exposure times are indicated in brackets. Corresponding phase contrast images are given
(third column). (D) Intensity of Irga6 loaded onto parasitophorous vacuoles in IFNc-induced MEFs infected with CTG Ble (black), CTG L1 (green), or
CTG V1 (red) transgenic T. gondii strains, detected with monoclonal anti-Irga6 antibody 10D7. Loading of Irga6 is inhibited by CTG V1; the effect is
greatest at low IFNc concentrations (0.3 U/ml) (horizontal lines indicate mean signal intensities; *** p,0.0001, * p,0.025). One representative out of
two independent experiments is shown.
doi:10.1371/journal.pbio.1000576.g008
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and PhosSTOP, Roche) for 30 min on ice. Postnuclear lysates were
subjected to SDS-PAGE and Western blot.
Expression Constructs
Wt and mutant Irga6 proteins were expressed from pGW1H
and pGEX-4T-2 vectors in mouse fibroblasts and Escherichia coli
BL21 respectively. The wt constructs were pGW1H-Irga6-ctag1
[16,24] and pGEX-4T-2-Irga6 [22], respectively, and the desired
mutants were generated in these constructs by site-directed
mutagenesis using the Quick-Change protocol (Stratagene). The
following mutant Irga6 proteins were generated: Irga6-T102A,
-T108A, -T102/108A, -T102D, -T108D and -T102/108D. Ctag1
was used as C-terminal epitope tag [24].
For expression in mouse fibroblasts, pGW1H constructs were
transfected using FuGENE6 (Roche) according to the manufac-
turer’s instructions. For biochemical analysis, proteins were
expressed from pGEX-4T-2 constructs as N-terminal GST fusion
protein and purified as described earlier [16]. The C-terminally
Ty-tagged mature form of RH-derived ROP18 was cloned via SalI
restriction from pGW1H-ROP18-Ty RH-YFP [12] into the bacterial
and yeast expression vectors pGEX-4T-2 (GE Healthcare) and
pGAD-C3/pGBD-C3 [47], respectively. Generation of pGAD-/
pGBD-Irga6 was described previously [16]. The kinase-dead ROP18-
D394Amutant (numbering refers to unprocessed form) was generated
by site-directed mutagenesis. Primers used were (including reverse
complement sequences): Irga6: T102A: 59-gggaatgaagaagaaggtgcagc-
taaagctggggtggtggaggtaaccatgg-39; T102D: 59-gggaatgaagaagaaggtg-







Expression and Purification of Recombinant ROP18
RH-derived ROP18 was expressed as a N-terminal GST fusion
protein from pGEX-4T-2 in E. coli BL21-CodonPlus (Stratagene)
Figure 9. ROP18 directly phosphorylates Irga6 at T102 and T108 in vitro. (A) Bacterially expressed, purified wt or T102A and T108A mutant
Irga6 proteins (300 ng) were coincubated with bacterially expressed, purified GST-ROP18-Ty (10 ml, 5 ml, 1.7 ml respectively; 1 ml ,20 ng) in the
presence of c32P-ATP in vitro. The autoradiogram reveals efficient phosphorylation of wt Irga6 and a decrease in signal intensity for all Irga6 alanine
mutants. This effect is most apparent at low ROP18 concentrations (1.7 ml). Autophosphorylation of ROP18 ((p)ROP18) is visible at higher kinase
concentrations (10 ml and unpublished data) by the appearance of two bands (as previously observed for immunoprecipitated endogenous ROP18
[55]). (B) Quantification of signal intensities observed in (A) for two different ROP18 concentrations (5 ml and 1.7 ml) by phosphorimaging. Black bars
represent two independent experiments. (C) Bacterially expressed purified wt or T102A and T108A mutant Irga6 proteins (300 ng) were coincubated
with GST-ROP18-Ty (10 ml) in the presence of 1 mM unlabelled ATP in vitro. One-third of each kinase reaction was resolved by SDS-PAGE and
subjected to Western blot analysis using the anti-pT102 and anti-pT108 antibodies (upper two blots) or a monoclonal anti-Irga6 antibody, 10E7
(lower blot). Alanine mutation of the target threonines in Irga6 (T102 and T108) specifically blocks recognition by the corresponding antibody.
doi:10.1371/journal.pbio.1000576.g009
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upon overnight induction with 0.1 mM IPTG at 18uC. The cells
were lysed in PBS containing 2 mM DTT, 1% Triton X-114 and
Complete Mini Protease Inhibitor Cocktail EDTA free (Roche)
using a French press (Thermo Scientific). Cleared lysates were
purified on a GSTrap FF glutathione Sepharose affinity column
(GE Healthcare) in PBS containing 2 mM DTT and 1% Triton
X-114. The GST-ROP18 fusion protein was eluted with PBS
containing 2 mM DTT, 1% Triton X-114, and 10 mM reduced
glutathione. Fractions containing ROP18 were subjected to size
exclusion chromatography (Superdex 200; GE Healthcare) in PBS
and 2 mM DTT. The remaining Triton X-114 was removed by
phase separation at 37uC for 2 min and centrifugation, with
ROP18 recovered from the aqueous phase. The protein was
concentrated with a Vivaspin centrifugal concentrator (Sartorius).
Amounts added to assays are cited as volume of the concentrate.
The approximate concentration estimated in a Coomassie spot test
[48] was 20 ng/ml.
In Vitro Kinase Assay
Bacterially derived, purified GST-ROP18 was coincubated with
wt or T102A, T108A, and T102/108A Irga6 mutants in 25 mM
Tris/HCl (pH 7.5) and 15 mM MgCl2 for 30 min at 30uC. Each
50 ml reaction contained either 2 mCi of c32P-ATP (Hartmann) for
autoradiography or 1 mM unlabelled ATP for Western blot
analysis. Samples were immediately boiled in sample buffer
(80 mM Tris/HCl [pH 6.8], 5 mM EDTA, 4% SDS, 34%
sucrose, 40 mM DTT, 0.002% bromophenol blue) for 5 min at
95uC and proteins were resolved by SDS-PAGE. Gels were dried
and exposed to Biomax MS film (Kodak) or subjected to Western
blot analysis.
Yeast Two-Hybrid Assay
The yeast two-hybrid assay was performed as described
previously [16].
Metabolic Labelling, Immunoprecipitation, and
Autoradiography
Cells were seeded as above onto 6 cm dishes, induced with
IFNc, washed, and preincubated in phosphate- or methionine/
cysteine-free medium for 0.5 h before labelling with 100 mCi/ml
33P- or 32P-phosphoric acid, 35S-methionine/cysteine (all Hart-
mann) or 200 mCi/ml 3H-myristic acid (Perkin Elmer). After 1 h
cells were infected, in the continued presence of label, with the
indicated T. gondii strains. After infection for 2 h, cells were washed
twice with ice-cold PBS and lysed in 500 ml 0.5% NP-40, 140 mM
NaCl, 2 mM Tris/HCl (pH 7.6) containing protease and
phosphatase inhibitors (Complete, Mini, EDTA free, and Phos-
STOP, Roche) for 30 min on ice. Postnuclear lysates were
incubated in the presence of specific antibodies or antisera
overnight followed by 2 h incubation with 50 ml of protein A–
Sepharose (Amersham) both at 4uC. Beads were washed once with
150 mM NaCl, 10 mM Tris/HCl (pH 7.6) and once with 10 mM
Tris/HCl (pH 8) and either stored at 280uC or immediately
boiled in sample buffer (80 mM Tris/HCl [pH 6.8], 5 mM
EDTA, 4% SDS, 34% sucrose, 40 mM DTT, 0.002% bromo-
phenol blue) for 5 min at 95uC. Proteins were resolved by SDS-
PAGE, and gels were dried and exposed to Biomax MS film
(Kodak) or imaged using a FLA3000 phosphorimager (Amer-
sham). For analysis of 3H-labelled proteins the gel was preincu-
bated with Autoradiography Enhancer (Perkin Elmer) for 1 h at
room temperature and intensively washed before autoradiography
of the dried gel.
Immunoreagents
Rabbit antisera were raised at Innovagen AB against the
following Irga6 phosphopeptides: Irga6 amino acids 97–107 (NH2-)
C-EGAAK(pT102)GVVEV (-CONH2), (serum 87555), and Irga6
amino acids 103–113 (NH2-) C-GVVEV(pT108)MERHP (-CONH2)
(serum 87558). In both cases, the N-terminal cysteine was added for
conjugation to carrier (KLH). The 5th bleeds of each antiserum were
first absorbed on the unphosphorylated peptide, and then affinity-
purified on the phosphopeptide. Other immunoreagents used were:
10D7 and 10E7 mouse monoclonal antibodies [24] and 165 rabbit
antiserum [23] against Irga6, anti-Irgb6 mouse monoclonal B34 [49],
anti-Irgb10 rabbit serum 939/4 raised against recombinant full-length
Irgb10, anti-ctag1 2600 rabbit antiserum [11], and anti-calnexin
antiserum (Calbiochem). Second-stage antibodies were: Alexa 488
and Alexa 555 labelled donkey anti-mouse and anti-rabbit sera
(Molecular Probes), goat anti-mouse-HRP (Pierce), and donkey anti-
rabbit-HRP (GE Healthcare) antibodies.
Immunofluorescence Microscopy and Analysis
For immunofluorescence microscopy, uninduced or IFNc-
induced cells grown on coverslips were infected or not with T.
gondii, washed in PBS, fixed in PBS/3% paraformaldehyde for
15 min at room temperature and permeabilised in ice-cold
methanol or 0.1% saponin at room temperature for 20 min
before immunostaining. Vacuoles containing intracellular tachy-
zoites were identified from the characteristic phase contrast image.
Microscopy and image analysis were performed essentially
according to Hunn et al. [16]. All slides were counted double-
blind, some independently by two observers. 100–500 vacuoles
were counted in two to four independent experiments. This
precaution is an essential control on observer bias in all
nonautomated assessment of fluorescent images. Individual
vacuoles for scoring were identified by a systematic scanning
procedure in phase contrast and scored positive or negative for
specific immunoreagents. Photographs of 20–40 vacuoles were
analysed for fluorescence intensity according to Khaminets et al.
[12]. Exposure times are indicated in brackets.
Statistical Analyses
Statistical analyses were performed as described previously [12].
Oligomerisation Assay
Oligomerisation of Irga6 was monitored by conventional light
scattering as described earlier [16].
Nucleotide Hydrolysis Assay
The nucleotide hydrolysis was measured by thin layer
chromatography and autoradiography as described earlier [16].
Nucleotide Binding Measurement
The nucleotide binding affinities were determined by equilib-
rium titration with mant-labelled nucleotides as described earlier
[16].
Mass Spectrometric Identification of Phosphorylated
Peptides
Irga6 proteins immunoprecipitated from IFNc-stimulated and
T. gondii RH-YFP or RH infected cells were separated by SDS-
PAGE and subsequently stained overnight in colloidal Coomassie
blue solution. After destaining the gel in H2O, phosphorylated and
nonmodified Irga6 bands were cut out and immediately subjected
to MALDI and Nano-LC ESI- MS/MS mass spectrometry.
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Tryptic In-Gel Digest
SDS-PAGE bands of interest were digested as described
elsewhere [50]. In brief, bands of interest were cut out and
minced. After destaining with 50% 10 mM NH4HCO3/50%
acetonitrile (ACN) at 55uC and dehydration in 100%ACN, gel
pieces were equilibrated with 10 mM NH4HCO3 containing
porcine trypsin (12.5 ng/ml; Promega, Mannheim) on ice for 2 h.
Excess trypsin solution was removed and hydrolysis was performed
for 4 h at 37uC in 10 mM NH4HCO3. Digests were acidified with
5% trifluoroacetic acid (TFA) and the gel pieces were extracted
twice with 0.1% TFA and then with 60% ACN/40% H2O/0.1%
TFA followed by a two-step treatment using 100% ACN.
Extractions were combined, concentrated by vacuum centrifuga-
tion, and desalted according to Rappsilber et al. [51].
Nano-LC ESI-MS/MS
Experiments were performed with an LTQ Orbitrap Discovery
mass spectrometer (Thermo) coupled to a split-less Eksigent nano-
LC system. Intact peptides were detected in the Orbitrap at
30,000 resolution in the mass-to-charge (m/z) range 400–2000
using m/z 445.120025 as a lock mass. Up to five CID spectra were
acquired following each full scan. Peptides were separated on a
10 cm, 75 mm C18 reversed phase column (Proxeon) within
140 min at a flow rate of 200 nl/min (buffer A: 0.5% acetic acid,
buffer B: 0.5% acetic acid, 80% ACN).
MALDI Mass Spectrometry
For peptide mass fingerprinting, 2500 spectra in the mass-to-
charge (m/z) range of 700–4,000 were acquired on a 4800 Plus
MALDI-TOF/TOF Analyzer (Applied Biosystems) in the reflec-
tor positive mode using a-cyano-4-hydroxycinnamic acid (CHCA)
(10 mg/ml, 50% ACN in 0.1% aqueous TFA). Automatic
annotation of monoisotopic peptide signals in tryptic digests was
performed using internal calibration on trypsin autolysis peaks at
m/z 842 and 2211.
Peptide and Protein Identification
Mascot 2.2 (Matrix Science) was used for protein identification
by searching the Swissprot database of Mus musculus [52]. Mass
tolerance for intact peptide masses was 20 ppm for MALDI MS
data and 10 ppm for Orbitrap data, respectively. Mass tolerance
for fragment ions detected in the linear ion trap was 0.8 Da.
Oxidation of methionine and phosphorylation of serine, threonine,
and tyrosine were set as variable modifications.
Software
Swiss-PDBViewer [53] and PyMOL v0.99 (DeLano Scientific)
were used for generation of crystal structure images. The
multisequence alignment was generated with ClustalW via the
EBI server (http://www.ebi.ac.uk/Tools/msa/clustalw2/) using
the default settings and edited and shaded with GeneDoc [54].
SigmaPlot v9 (Systat) was used for dissociation constant calcula-
tion. AIDA Image Analyser v3 (Raytest) and ImageQuant TL v7
(GE Healthcare) were used for quantification of photostimulated
luminescence. MS spectra analysis and peak annotation was
performed using the MaxQuant software version 1.1.1.2.
Supporting Information
Figure S1 Irga6-T102 and -T108 phosphopeptides iden-
tified by mass spectrometry. (A) Reversed phase chromato-
gram of the peptides with m/z 608.767 (mass tolerance 5 ppm)
shown in Figure 2A, derived from immunoprecipitated, phos-
phorylated Irga6 after SDS-PAGE separation, tryptic digest and
nano-LC ESI-MS/MS acquired on a LTQ/Orbitrap mass
spectrometer. This m/z corresponds to two monophosphorylated
peptides with the sequence TGVVEVTMER that eluted as two
distinct peaks. (B and C) CID fragment spectrum of two peptides
with m/z 608.767 separated in (A). For the first elution peak
(Mascot ion score 31, delta mass +0.21 ppm) the masses of the
fragment ions y4–y9 that contain T108 indicate that this residue is
phosphorylated whereas the fragment ions b3–b5 containing T102
show no modification (B). For the second elution peak (Mascot ion
score 37, delta mass 20.7 ppm) the masses of the fragment ions
b3–b6 containing T102 indicate that this residue is phosphorylat-
ed whereas the fragment ions y5–y7 and y9 contain T108 and
show no modification (C). Peaks labelled with an asterisk (*)
correspond to fragment ions displaying a neutral loss of phosphoric
acid (H3PO4, 98 Da).
Found at: doi:10.1371/journal.pbio.1000576.s001 (1.02 MB TIF)
Figure S2 Specificity of rabbit anti-phosphothreonine
antibodies anti-pT102 and anti-pT108 demonstrated
with Irga6-deficient cells. (A) Anti-pT102 and anti-pT108
antibodies detect phosphorylated Irga6 (black arrowhead) in
Western blot only from IFNc-induced wt MEFs infected with
virulent RH-YFP strain T. gondii. No signals were detected in RH-
YFP-infected, IFNc-induced MEFs from Irga6-deficient (Irga62/2)
mice. (B) Anti-pT102 and anti-pT108 antibodies detect phos-
phorylated Irga6 at the PV in IFNc-induced wt MEFs infected
with virulent RH strain T. gondii. Immunofluorescent signal
intensities were measured on 20 vacuoles. Negligible signals were
detected at the vacuole in IFNc-induced, RH-infected, Irga6-
deficient MEFs.
Found at: doi:10.1371/journal.pbio.1000576.s002 (0.59 MB TIF)
Figure S3 Specificity control of rabbit anti-phospho-
threonine antibodies anti-pT102 and anti-pT108 for
Figure 6. Rabbit anti-phosphothreonine antibodies give no
immunofluorescent signals on parasitophorous vacuoles of virulent
(RH-YFP, upper two rows) or avirulent (ME49, lower two rows)
infected MEFs in the absence of induction by IFNc. Intracellular
T. gondii are indicated by arrows and individual exposure times are
indicated in brackets.
Found at: doi:10.1371/journal.pbio.1000576.s003 (2.27 MB TIF)
Figure S4 Specificity control of rabbit anti-phospho-
threonine antibodies anti-pT102 and anti-pT108 for
Figure 8. Rabbit anti-phosphothreonine antibodies give no
immunofluorescent signals on parasitophorous vacuoles of CTG
strains transgenic for active virulent ROP18 (CTG V1), kinase-
dead ROP18-D394A (CTG L1) or empty vector (CTG Ble) in the
absence of induction by IFNc. Intracellular T. gondii are indicated
by arrows and individual exposure times are indicated in brackets.
Found at: doi:10.1371/journal.pbio.1000576.s004 (2.10 MB TIF)
Figure S5 Direct interaction of ROP18 with Irga6. Yeast
two-hybrid analysis of the interaction of wt RH strain ROP18 and
kinase-dead ROP18-D394A with Irga6. Growth on selective
medium (SD medium lacking leucine, tryptophan, and histidine
containing 1 mM 3-amino-1,2,4-triazole) indicative of protein–
protein interaction is shown (day 20). Irga6 self-interaction [16]
was used as a positive control and the empty expression vectors as
negative controls.
Found at: doi:10.1371/journal.pbio.1000576.s005 (1.17 MB TIF)
Figure S6 Irgb6 and Irgb10 are phosphorylated upon
type I virulent strain infection. Irgb6 and Irgb10 were
immunoprecipitated from IFNc-induced or transiently transfected,
metabolically labelled L929 cells and infected with virulent T.
gondii strain RH-YFP or CTG transgenic T. gondii strains. (A) A
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weak 32P-inorganic phosphate labelled band corresponding to
Irgb6 (black arrowhead on the left) was immunoprecipitated with
mouse monoclonal anti-Irgb6 antibody, B34, only from IFNc-
induced cells. A very weakly labelled nonspecific band running
above the positive control Irga6 (black arrowhead on the right)
protein (precipitated with 10E7 antibody) is indicated by an
asterisk. (B) A montage of autoradiograms showing immunopre-
cipitation of Irga6 (left panel), Irgb10 (middle panel) from RH-
YFP-infected, CTG transgenic strain-infected, or uninfected L929
cells labelled with 33P-phosphoric acid. The Irga6 results serve as
positive controls (black arrowhead on the left). Phosphorylated
Irgb10 (black arrowhead on the left) could be reproducibly
immunoprecipitated from uninfected, IFNc-induced cells, but the
signal was enhanced by RH-YFP infection. Two nonspecific
labelled bands precipitated by the anti-Irgb10 antiserum are
indicated with asterisks. The right panel shows the specificity of the
rabbit anti-Irgb10 antiserum, precipitating Irgb10 but not Irga6
from 35S-methionine/cysteine metabolically labelled cells (open
arrowheads on the right). Two nonspecifically immunoprecipitat-
ed labelled bands are indicated with asterisks. (C) Recombinant
Irga6-ctag1 and Irgb10-ctag1 proteins were immunoprecipitated
from transiently transfected, IFNc-induced, 33P-labelled cells.
Phosphorylation of Irgb10 could be demonstrated in uninfected
cells but the signal intensity was strongly increased upon infection
with virulent RH-YFP T. gondii (black arrowhead on the right).
Phosphorylation of Irga6 was strictly dependent on infection and
served as a positive control (black arrowhead on the left).
Found at: doi:10.1371/journal.pbio.1000576.s006 (1.55 MB TIF)
Table S1 Nucleotide binding affinities of Irga6-T102
and -T108 mutants. Dissociation constant (Kd) measured by
equilibrium titration with mant-nucleotides. The mean values and
the standard deviation of at least two independent experiments are
given.
Found at: doi:10.1371/journal.pbio.1000576.s007 (0.19 MB TIF)
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